RICHMOND, BRITISH COLUMBIA--(Marketwire - June 4, 2008) - Medical Ventures Corp. (TSX VENTURE:MEV), a company developing and marketing specialty vascular devices, today announced that its shareholders approved all ordinary and special resolutions by requisite majorities at its Annual and Special Meeting of Shareholders held on June 3, 2008. Over 99% of eligible shareholders, voting either at the meeting or by proxy, approved resolutions for the Company to acquire two vascular device firms; to implement a 1:20 share consolidation; and to change the name of Medical Ventures Corp. to Neovasc Inc.
